OCGN / WHO's Nod Can't Mask Ocugen's Flimsy Fundamentals

Ocugen (NASDAQ: OCGN ) stock is on the rise Tuesday after the clinical-stage biopharmaceutical company announced a new vaccine trial. According to a p more_horizontal

MALVERN, Pa., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, d more_horizontal

Shares of Ocugen (NASDAQ: OCGN ) stock have been on the move today. Following a surge of more than 3% this morning, shares of OCGN stock have since more_horizontal

Ocugen (NASDAQ: OCGN ) stock has trended steadily downward for the past six months, shedding almost 70% of its value. While things have looked bleak f more_horizontal

Ocugen (NASDAQ: OCGN ) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering. Ocugen has announced that more_horizontal

MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, de more_horizontal

Ocugen (NASDAQ: OCGN ) stock is on the move Friday after the company revealed preliminary results from an ongoing clinical trial. The preliminary resu more_horizontal

The company is clearly progressing on several fronts with its pipeline programs. more_horizontal